Rhythm Pharmaceuticals's market cap is currently $3.55B. The company's EPS TTM is $-4.338; its P/E ratio is ―; Rhythm Pharmaceuticals is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.69. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 77.43M	$ 23.64M	$ 3.15M	$ 0.00	$ 0.00
Gross Profit	$ 68.13M	$ 21.50M	$ 2.56M	$ -690.00K	$ -834.00K
Operating Income	$ -184.36M	$ -179.16M	$ -170.06M	$ -136.57M	$ -146.00M
EBITDA	$ -168.46M	$ -174.51M	$ -68.45M	$ -135.88M	$ -145.17M
Net Income	$ -184.68M	$ -183.08M	$ -68.01M	$ -130.73M	$ -134.62M
Balance Sheet
Cash & Short-Term Investments	$ 275.85M	$ 333.29M	$ 294.86M	$ 172.79M	$ 292.46M
Total Assets	$ 332.75M	$ 382.48M	$ 329.52M	$ 187.07M	$ 308.52M
Total Debt	$ 1.26M	$ 1.94M	$ 2.55M	$ 3.09M	$ 3.56M
Net Debt	$ -58.82M	$ -125.73M	$ -56.70M	$ -97.77M	$ -58.74M
Total Liabilities	$ 162.99M	$ 118.22M	$ 45.37M	$ 20.55M	$ 27.50M
Stockholders' Equity	$ 169.76M	$ 264.26M	$ 284.15M	$ 166.53M	$ 281.02M
Cash Flow
Free Cash Flow	$ -136.20M	$ -177.71M	$ -151.44M	$ -122.19M	$ -126.14M
Operating Cash Flow	$ -136.16M	$ -173.43M	$ -146.00M	$ -121.98M	$ -122.75M
Investing Cash Flow	$ -5.67M	$ 28.03M	$ -62.16M	$ 158.53M	$ -27.97M
Financing Cash Flow	$ 74.37M	$ 213.83M	$ 166.48M	$ 2.01M	$ 163.47M

Currency in USD

Rhythm Pharmaceuticals Earnings and Revenue History

Income Statement >

Rhythm Pharmaceuticals Debt to Assets

Balance Sheet >

Rhythm Pharmaceuticals Cash Flow

Cash Flow >

Rhythm Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing